Filing Details
- Accession Number:
- 0001209191-22-035417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-09 16:42:23
- Reporting Period:
- 2022-06-07
- Accepted Time:
- 2022-06-09 16:42:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1357874 | Precision Biosciences Inc | DTIL | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769828 | Derek Jantz | C/O Precision Biosciences, Inc. 302 E. Pettigrew Street, Suite A-100 Durham NC 27701 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-07 | 29,545 | $0.00 | 4,061,824 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-06-07 | 12,199 | $0.00 | 4,074,023 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-08 | 18,849 | $2.06 | 4,055,174 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2022-06-07 | 29,545 | $0.00 | 29,545 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2022-06-07 | 12,199 | $0.00 | 12,199 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,545 | No | 4 | M | Direct | ||
| 24,391 | No | 4 | M | Direct |
Footnotes
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.
- Each RSU represents a contingent right to receive one share of the Company's Common Stock.
- The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
- On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to theReporting Person's continued service to the Company through the applicable vesting dates.
- On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Billionaire Hedge Funds
